Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Clearance for first-in-human study of ORBCEL-M for diabetic kidney disease

Aug. 7, 2017

FDA grants orphan drug designation to OMS-721 for IgA nephropathy

Aug. 7, 2017

Quark Pharmaceuticals reports positive results from QPI-1002 phase II study

July 28, 2017

Encouraging phase IIa results for DMX-200 in patients with proteinuria

July 14, 2017

Results from phase I trial of oral CR-845 in hemodialysis patients with CKD

July 13, 2017

Bardoxolone methyl granted U.S. orphan drug status for Alport syndrome

July 10, 2017

ADV-7103 granted E.U. orphan drug designation for distal renal tubulopathy acidosis

July 7, 2017

Human adipose-derived stromal cells effectively treat experimental glomerulonephritis

July 5, 2017

Clarus resubmits NDA for Jatenzo

June 27, 2017

Novel SSAO inhibitor UD-014 ameliorates experimental diabetic nephropathy

June 26, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...